Priorix was first launched in Europe almost a quarter of a century ago by GSK's predecessor SmithKline Beecham, and is a combination measles, mumps and rubella (MMR) vaccine now cleared by the FDA ...

GSK celebrates 100 years in India with former MDs, highlighting resilience and reinvention in the pharmaceutical industry.

But it's not just about money. The creation of GlaxoSmithKline, forged out of the merger of Glaxo Wellcome and SmithKline Beecham three and a bit years ago, gives him the chance to make a ...

Amid the exit plan of Glaxo Consumer Nigeria Plc ... “Other than Setfirst Limited and SmithKline Beecham Limited, who have notified the company that they have elected not to receive their ...

GlaxoSmithKline was formerly called GlaxoWelcome before its merger with U.S. pharmaceutical company SmithKline Beecham in 2000. The combination has made GlaxoSmithKline the 6th largest ...

Of these Downward was merged with Qualtrough as part of the SmithKline Beecham-Glaxo group and is now the only survivor of the industry. Over the years these bottles have become relatively rare ...

Iodex is the market leader in the pain-balm segment, with a market share of 70 per cent-plus. Iodex faces challenges from local brands like Amrutanjan, Tiger Balm (locally manufactured by Elder ...

In the 1970s, paroxetine hydrochloride (PHC) anhydrates were invented in the UK and, in 1998, a PHC hemihydrate compound was patented by GSK (then SmithKline Beecham) and marketed as Paxil.

Please pass this message over to your loved ones," have been doing the rounds. Glaxo SmithKline, however, denied the allegations. Confirming the rumours about counterfeit 'Panadol Extra' are ...

Centrum is bearish on Glaxo SmithKline Pharma has recommended sell rating on the stock with a target price of Rs 950 in its research report dated October 22, 2018. Sell Glaxo SmithKline Pharma ...